Evaluation of ICP-B381 in Patients With Advanced Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B381 in the trial participants of advanced solid tumors
Epistemonikos ID: 996cf5eb6d551fbd85b97d890540b5b6a9529cbb
First added on: Oct 29, 2026